Startseite
Märkte
Charts & Ideen
Algo
Nachrichten
Store
Broker
Herunterladen
Wirtschaftskalender
Handelssignale
WebTerminal
Geben Sie
/
ein, um zu suchen: @user, $symbol
Suche
Einloggen
Eröffnen Sie ein Konto
Deutsch
English
Русский
中文
Español
Português
日本語
한국어
Français
Italiano
Türkçe
ZNTL
#3078
Zentalis Pharmaceuticals, Inc. Common Stock
2.3
9
-0.42%
Sektor:
Basis:
Gewinnwährung:
Tagesspanne
Jahresspanne
Tagesänderung
-0.42%
Monatliche Änderung
-18.98%
6 month change
+32.78%
Jahresänderung
+17.73%
Vorheriger Schlusskurs
2.4
0
Open
2.3
9
Bid
Ask
Low
2.3
9
High
2.3
9
Volumen
70
Märkte
Aktien
Gesundheitswesen
ZNTL
Open full chart
Financials
Overview
Finanzbericht
Statistics
Dividends
Quarterly
Annual
Value
Q3, 24
Q4, 24
Q1, 25
Q2, 25
Q3, 25
TTM
Key stats
Total common shares outstanding
71.27 M
71.81 M
71.95 M
72.14 M
72.25 M
—
Valuation ratios
Enterprise value
220.94 M
183.69 M
72.47 M
46.08 M
70.03 M
372.27 M
Price to earnings ratio
-1.52
-1.3
-0.51
-0.51
-0.73
-3.04
Price to sales ratio
6.39
3.19
4.21
3.07
4
14.47
Price to cash flow ratio
-1.49
-1.26
-0.75
-0.55
-0.81
-3.36
Price to book ratio
0.16
0.64
0.08
0.07
0.09
0.88
Enterprise value to EBITDA ratio
—
—
—
—
—
—
Profitability ratios
Return on assets %
0.09
0.06
0.13
0.08
0.08
0.35
Return on equity %
0.11
0.08
0.16
0.1
0.11
0.45
Return on invested capital %
80.77
67.11
111.94
355.03
341.36
875.44
Gross margin %
—
100
—
—
—
—
Operating margin %
—
185.55
—
—
—
—
EBITDA margin %
—
—
—
—
—
—
Net margin %
—
101.75
—
—
—
—
Liquidity ratios
Quick ratio
—
—
—
—
—
—
Current ratio
7.29
7.32
6.94
7.99
7.76
30
Inventory turnover
—
—
—
—
—
—
Asset turnover
0
0.06
0
0
0
0.06
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
Long term debt to total assets ratio
—
—
—
—
—
—
Long term debt to total equity ratio
—
—
—
—
—
—
Per share metrics
Operating cash flow per share
0.62
0.56
0.46
0.48
0.37
1.87
EBIT per share
—
—
—
—
—
—
EBITDA per share
—
—
—
—
—
—
Total debt per share
—
—
—
—
—
—
Cash per share
1.14
1.3
5.33
5.18
4.72
16.53
Net current asset value per share
5.63
5.43
4.78
4.33
4
18.54
Tangible book value per share
4.93
4.74
4.12
3.81
3.51
16.18
Working capital per share
4.86
4.69
4.09
3.79
3.48
16.05
Book value per share
4.98
4.74
4.12
3.81
3.51
16.18
Nachrichten
CEO von Zentalis Pharma veräußert Aktien im Wert von 21.000 $
Zentalis Pharma CEO Eastland sells $21k in shares
Zentalis Pharma: CMO Bruns verkauft Aktien im Wert von rund 8.000 US-Dollar
Insider-Verkauf bei Zentalis Pharmaceuticals: PAO veräußert Aktien im Wert von 97.556 $
Zentalis Pharma CMO Bruns sells $7998 in stock
Großaktionär Walters Group investiert 7,7 Mio. US-Dollar in Zentalis Pharmaceuticals
Zentalis Pharmaceuticals: Late Stage, Lots Of Cash, Crushed By The Market
Zentalis Pharmaceuticals: Hanging On For One Last Shot At PROC Approval (ZNTL)
Leerink Partners senkt Kursziel für Zentalis Pharmaceuticals auf 2 US-Dollar/n
Zentalis Pharmaceuticals stock price target lowered to $2 at Leerink Partners
Zentalis to present azenosertib data at cancer therapeutics conference
Zentalis Pharmaceuticals shareholders elect three directors at annual meeting